Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy FDA accelerated approval ,Office of Inspector General ,aducanumab approval,clinical trial data,alzheimer disease FDA

	Profile	Recent Articles on Subject
1	1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	NHS medicines access in jeopardy says ABPI - over 1 year ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Illuccix therapy gets approval in the UK - 19 days ago Novartis secures MHRA authorisation for ribociclib - 27 days ago Pheno Therapeutics granted trial authorisation for MS candidate - about 2 months ago Amgen’s lung cancer treatment gets conditional approval - about 2 months ago UK regulator warns against buying weight-loss medicines without prescription - 2 months ago MHRA grants approval for bladder cancer drug erdafitinib - 4 months ago Scotland first in UK to approve new myeloma treatment - 6 months ago UCB announces MHRA approval for UCB’s Zilbrysq - about 1 year ago
3	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	4 closely watched FDA approval dates in 2025 from J&J, Novo and more - about 2 months ago Pfizer’s new shot approval adds to a growing vaccine prowess - over 1 year ago
4	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The first MASH drug could open the door for others — including GLP-1s - 4 months ago 3 FDA approval dates to watch in the year’s final push - 6 months ago FDA’s platform designation aims to ease R&D pain points - 9 months ago With historic MASH approval, Madrigal preps for launch and a public offering - 12 months ago
5	Susan Kelly MedTech Dive Leader, teacher, learner. St. John's youthtech sector	J&J wins FDA approval for Varipulse PFA system - 4 months ago UK medical device reviewers form new association - about 1 year ago
6	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum? - 5 months ago 3 recent FDA adcomm rejections — and why they matter - over 1 year ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts Resubmitted NDA for AXS-07 for Acute Treatment of Migraine - 6 months ago FDA Grants Marketing Authorization for Rapid Hepatitis C Test - 8 months ago FDA Accepts New Drug Application for MDMA-Assisted Therapy for PTSD - about 1 year ago
8	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Highly Anticipated FDA Decision Comes Just in Time for Back-to-School Season - 6 months ago
9	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 6 months ago eXmoor pharma’s manufacturing facility receives licence from MHRA - 7 months ago
10	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - 7 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 12 months ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - over 1 year ago STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data - over 1 year ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - over 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - over 1 year ago STAT+: Lilly complains to the U.S. International Trade Commission about unapproved versions of Mounjaro - over 1 year ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - over 1 year ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - over 1 year ago

Journalists covering MHRA manufacturing approval